abi-1968
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 11, 2017 (NCT03202992)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human papillomavirusINHIBITOR
Human papillomavirus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03697226 | Phase 1 | Dec 21, 2018 | Antiva Biosciences |
| NCT03677960 | Phase 1 | Sep 20, 2018 | Antiva Biosciences |
| NCT03239223 | Phase 1 | Jan 1, 2018 | Antiva Biosciences |
| NCT03202992 | Phase 1 | Aug 11, 2017 | Antiva Biosciences |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Antiva Biosciences | For profit | 4 | 4 | 1 | 2017 |
1 organizations
Page 1 / 1